Stocks

Adaptimmune Therapeutics ADAPY

Health care sectorOTC markets

Company

Exchange
OTC markets
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Abingdon, Oxfordshire
Fiscal year end
12/31
Next earnings
25/11/13, estimated

5% stakes

Holder
Long Focus Capital Management02/170%0 sh−8.0pp
Two Seas Capital25/11/140%0 sh−8.5pp
New Enterprise Associates 1425/08/190%4 shNo earlier report
Two Seas Capital25/05/158%123,178,110 sh+2.2pp
Two Seas Capital25/02/145.8%89,010,876 shFirst report
All 5% stake reports on Adaptimmune Therapeutics

26-week trading